[go: up one dir, main page]

DE602004030007D1 - 2-aminobicyclo 3.1.0 hexan-2,6-dicarbonsäureesterderivat - Google Patents

2-aminobicyclo 3.1.0 hexan-2,6-dicarbonsäureesterderivat

Info

Publication number
DE602004030007D1
DE602004030007D1 DE602004030007T DE602004030007T DE602004030007D1 DE 602004030007 D1 DE602004030007 D1 DE 602004030007D1 DE 602004030007 T DE602004030007 T DE 602004030007T DE 602004030007 T DE602004030007 T DE 602004030007T DE 602004030007 D1 DE602004030007 D1 DE 602004030007D1
Authority
DE
Germany
Prior art keywords
hydrogen atom
alkyl group
different
drug
dicarbonsäureesterderivat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004030007T
Other languages
English (en)
Inventor
Akito Yasuhara
Kazunari Sakagami
Hiroshi Ohta
Atsuro Nakazato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of DE602004030007D1 publication Critical patent/DE602004030007D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
DE602004030007T 2003-06-26 2004-06-25 2-aminobicyclo 3.1.0 hexan-2,6-dicarbonsäureesterderivat Expired - Lifetime DE602004030007D1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2003181930 2003-06-26
JP2003373511 2003-10-31
JP2004128663 2004-04-23
PCT/JP2004/009398 WO2005000791A1 (ja) 2003-06-26 2004-06-25 2-アミノ-ビシクロ[3.1.0]ヘキサン-2,6-ジカルボン酸エステル誘導体

Publications (1)

Publication Number Publication Date
DE602004030007D1 true DE602004030007D1 (en) 2010-12-23

Family

ID=33556154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004030007T Expired - Lifetime DE602004030007D1 (en) 2003-06-26 2004-06-25 2-aminobicyclo 3.1.0 hexan-2,6-dicarbonsäureesterderivat

Country Status (20)

Country Link
US (5) US7960579B2 (de)
EP (3) EP2123630B1 (de)
JP (1) JP4792971B2 (de)
KR (1) KR101071507B1 (de)
AT (1) ATE487690T1 (de)
AU (2) AU2004252017B2 (de)
BR (1) BRPI0411823A (de)
CA (1) CA2530706C (de)
CY (1) CY1110997T1 (de)
DE (1) DE602004030007D1 (de)
DK (2) DK2123630T3 (de)
ES (1) ES2394175T3 (de)
HR (1) HRP20100619T1 (de)
MX (1) MXPA05013740A (de)
NO (1) NO335004B1 (de)
NZ (2) NZ580554A (de)
PL (1) PL1637517T3 (de)
PT (1) PT1637517E (de)
SI (1) SI1637517T1 (de)
WO (1) WO2005000791A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2123630T3 (da) * 2003-06-26 2012-10-22 Braincells Inc 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarboxylsyreesterderivat
TW201129700A (en) 2009-11-18 2011-09-01 Taisho Pharmaceutical Co Ltd Method for producing optically active bicyclo [310] hexane derivative using oxygen
TW201124372A (en) 2009-11-19 2011-07-16 Taisho Pharmaceutical Co Ltd Process for producing 3-alkoxy-2-amino-6-fluorobicyclo[310]hexane-2,6-dicarboxylic acid derivative and intermediate thereof
AR083845A1 (es) 2010-11-18 2013-03-27 Lilly Co Eli COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR2/3
US9056844B2 (en) * 2010-11-18 2015-06-16 Eli Lilly And Company 4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists
WO2013062680A1 (en) * 2011-10-25 2013-05-02 Braincells, Inc. Novel compounds and compositions thereof for treating nervous system disorders
AR089718A1 (es) 2012-02-01 2014-09-10 Lilly Co Eli AGONISTAS DE mGlu2/3
JP5983713B2 (ja) * 2013-11-29 2016-09-06 大正製薬株式会社 含フッ素アミノ酸のプロドラッグを含有する医薬
FR3026843B1 (fr) * 2014-10-03 2016-11-18 Univ Pierre Et Marie Curie Paris 6 Procede de caracterisation du mecanisme de fissuration d'un materiau a partir de sa surface de rupture
ES2886442T3 (es) 2016-04-18 2021-12-20 Taisho Pharmaceutical Co Ltd Profármaco de derivado de aminoácido
CN110191709A (zh) 2017-01-17 2019-08-30 德州大学系统董事会 可用作吲哚胺2,3-双加氧酶和/或色氨酸双加氧酶抑制剂的化合物
KR101877672B1 (ko) 2017-04-03 2018-07-11 엘에스산전 주식회사 Ad컨버터
US11046649B2 (en) 2018-07-17 2021-06-29 Board Of Regents, The University Of Texas System Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US11501618B1 (en) * 2018-10-19 2022-11-15 Amazon Technologies, Inc. Security device with user-configurable motion detection settings
CN116444470B (zh) * 2023-03-29 2025-04-04 河南中烟工业有限责任公司 一种二羧酸二ddmp酯类化合物、制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750566A (en) * 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids
GB9605429D0 (en) 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
ZA983930B (en) 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
JP4194715B2 (ja) 1998-08-31 2008-12-10 大正製薬株式会社 6−フルオロビシクロ[3.1.0]ヘキサン誘導体
DE69918136T2 (de) 1998-08-31 2005-07-07 Taisho Pharmaceutical Co., Ltd. 6-Fluorobicyclo[3.1.0]Hexan-Derivate
CH694053A5 (de) 1998-09-03 2004-06-30 Hoffmann La Roche Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
AU6785401A (en) * 2000-06-28 2002-01-08 Taisho Pharmaceutical Co Ltd Novel dicarboxylic acid derivatives
WO2002068380A1 (en) 2001-02-22 2002-09-06 Eli Lilly And Company Synthetic excitatory amino acids
NZ533699A (en) * 2001-12-27 2006-05-26 Taisho Pharmaceutical Co Ltd 6-fluorobicyclo[3.1.0]hexane derivatives
DK2123630T3 (da) * 2003-06-26 2012-10-22 Braincells Inc 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarboxylsyreesterderivat
US7381746B2 (en) * 2003-06-26 2008-06-03 Taisho Pharmaceutical Co., Ltd. 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative
JP2007063129A (ja) * 2003-06-26 2007-03-15 Taisho Pharmaceut Co Ltd 2−アミノ−3−アルコキシビシクロ[3.1.0]ヘキサン誘導体

Also Published As

Publication number Publication date
NO20060428L (no) 2006-03-10
CA2530706A1 (en) 2005-01-06
NZ580554A (en) 2011-01-28
ATE487690T1 (de) 2010-11-15
CY1110997T1 (el) 2015-06-11
DK1637517T3 (da) 2011-01-31
ES2394175T3 (es) 2013-01-23
NZ544131A (en) 2009-11-27
EP1637517A4 (de) 2007-05-23
EP2123630A1 (de) 2009-11-25
HRP20100619T1 (hr) 2011-01-31
US20100298561A1 (en) 2010-11-25
US8039647B2 (en) 2011-10-18
US8350060B2 (en) 2013-01-08
US7960579B2 (en) 2011-06-14
EP2287147B1 (de) 2013-05-15
NO335004B1 (no) 2014-08-25
AU2009217374B2 (en) 2011-03-03
EP2287147A3 (de) 2011-05-18
AU2004252017B2 (en) 2009-10-08
EP1637517B1 (de) 2010-11-10
PT1637517E (pt) 2011-01-31
JP4792971B2 (ja) 2011-10-12
PL1637517T3 (pl) 2011-04-29
KR101071507B1 (ko) 2011-10-10
US20120004232A1 (en) 2012-01-05
SI1637517T1 (sl) 2011-01-31
US8076502B2 (en) 2011-12-13
KR20060024817A (ko) 2006-03-17
AU2009217374A1 (en) 2009-10-08
US20090306408A1 (en) 2009-12-10
AU2004252017A1 (en) 2005-01-06
EP2123630B1 (de) 2012-07-25
BRPI0411823A (pt) 2006-08-08
EP2287147A2 (de) 2011-02-23
US20070021394A1 (en) 2007-01-25
CA2530706C (en) 2012-11-27
EP1637517A1 (de) 2006-03-22
US20120028982A1 (en) 2012-02-02
JPWO2005000791A1 (ja) 2006-10-19
MXPA05013740A (es) 2006-05-17
DK2123630T3 (da) 2012-10-22
HK1095318A1 (zh) 2007-05-04
WO2005000791A1 (ja) 2005-01-06
US8258133B2 (en) 2012-09-04

Similar Documents

Publication Publication Date Title
DE602004030007D1 (en) 2-aminobicyclo 3.1.0 hexan-2,6-dicarbonsäureesterderivat
MY139357A (en) Novel benzoimidazole derivatives useful as antiproliferative agents
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
AU2002239463A1 (en) Cyclopenta(b)(1,4) diazepino(6,7,1-hi)indoles as 5ht2c antagonists
MX2007004183A (es) Derivados de benzoimidazol utiles como agentes antiproliferacion.
MY128765A (en) Novel benzoimidazole derivatives useful as antiproliferative agents.
MXPA05006420A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal.
TW200726765A (en) Triazolopyridine cannabinoid receptor 1 antagonists
NZ515894A (en) Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
BRPI0413876A (pt) tienopiridin-fenilacetamidas e seus derivados úteis como agentes antiangiogênicos
SG155938A1 (en) Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
AP2002002664A0 (en) Cyclohexylamine derivative as subtype selective NMDA receptor antagonists.
DE69227088D1 (de) Verwendung von 1-(aminoalkyl)-3-Quinoxalin-2-on Derivaten zur Herstellung von neuroprotektiven Mitteln
MY138547A (en) N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
MY122731A (en) 4-phenyl-pyrimidine derivatives
MXPA05006271A (es) Metodo para el tratamiento de desordenes del movimiento usando derivados de acido barbiturico.
NZ533358A (en) 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
TW200637552A (en) Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
EP1650191A4 (de) Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel
TW200519099A (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications
NO20053612L (no) 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet
SG153727A1 (en) Substituted pyridinones as modulators of p38 map kinase